<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04710693</url>
  </required_header>
  <id_info>
    <org_study_id>245862</org_study_id>
    <nct_id>NCT04710693</nct_id>
  </id_info>
  <brief_title>Implementation of Optical Diagnosis of Diminutive Colorectal Polyps in Real Life Clinical Practice: DISCARD3 Study</brief_title>
  <official_title>Implementation of Optical Diagnosis of Diminutive Colorectal Polyps in Real Life Clinical Practice: DISCARD3 Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>London North West Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>London North West Healthcare NHS Trust</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective feasibility study. The aim of this work is to assess the acceptability&#xD;
      and feasibility of optical diagnosis-led care in bowel cancer screening patients undergoing&#xD;
      colonoscopy. This study will determine whether bowel cancer screening colonoscopists are able&#xD;
      to consistently record and diagnose diminutive adenomas suitable for a resect and discard&#xD;
      strategy allowing assignment of surveillance intervals according to Preservation and&#xD;
      Incorporation of Valuable Endoscopic Innovations (PIVI) criteria. A practical quality&#xD;
      assurance program around optical diagnosis will be introduced. The use of a CAD&#xD;
      polyp-detection system will also be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Colonoscopy lists will be randomised for the use of a CAD polyp-detection system to be used as an adjunct to optical diagnosis. 50% of colonoscopy lists will be randomly assigned to use the CAD system and 50% of colonoscopy lists will not use the CAD system.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of optical diagnosis</measure>
    <time_frame>2 weeks for each participant</time_frame>
    <description>The sensitivity of optical diagnosis will be assessed for polyps identified during the course of the study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of optical diagnosis</measure>
    <time_frame>2 weeks for each participant</time_frame>
    <description>The specificity of optical diagnosis will be assessed for polyps identified during the course of the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Polyp/adenoma detection rate</measure>
    <time_frame>2 weeks for each participant</time_frame>
    <description>We will assess the impact on polyp/adenoma detection rate when using a CAD polyp-detection system.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">588</enrollment>
  <condition>Colonic Polyp</condition>
  <arm_group>
    <arm_group_label>CAD polyp-detection system</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In this arm, a CAD polyp detection system will be used during the colonoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard (no CAD polyp-detection system)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In this arm, a CAD polyp detection system will not be used during the colonoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CAD polyp-detection system</intervention_name>
    <description>Software will be used during the procedure to aid the detection of polyps during the procedure.</description>
    <arm_group_label>CAD polyp-detection system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 60-74&#xD;
&#xD;
               -  with +ve Faecal Occult Blood/Faecal Immunochemical test attending for screening&#xD;
                  colonoscopy within BCSP (Bowel Cancer Screening Programme)&#xD;
&#xD;
               -  with an established history of adenomas attending for surveillance colonoscopy&#xD;
                  within BCSP&#xD;
&#xD;
          -  Patients aged 55 - referred for screening colonoscopy following positive Bowel Scope&#xD;
             Screening flexible sigmoidoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a risk profile (due to family history or other) whose follow-up will be&#xD;
             outside standard BCSP&#xD;
&#xD;
          -  Patients with inflammatory bowel disease&#xD;
&#xD;
          -  Unable to consent&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St Mark's Hospital</name>
      <address>
        <city>Harrow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunder Chita</last_name>
      <phone>+44 (0) 20 8869 5829</phone>
      <email>sunderchita@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Brian Saunders</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Wilson</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ahmir Ahmad</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyps</mesh_term>
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

